ArticleBMC cancer2016

Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.

Pierre Kunz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.